Publications

255 publications

Enter search criteria

Fill in keyword(s) to narrow your search.

Periode

Enter a start and/or end date here, using the following format: DD-MM-YYYY.

You can select a specific type of a publication you are looking for, such as press releases or speeches

Semaglutide (Ozempic®) for the treatment of adults with insufficiently controlled type 2 diabetes mellitus as an adjunct to diet and exercise

Zorginstituut Nederland carried out a marginal assessment of whether semaglutide (Ozempic®) is interchangeable with a drug ...

Report | 28-08-2018

Working method for the Zinnige Zorg (appropriate care) Programme

Zorginstituut Nederland’s motto is "Taking care of good health care: no more and no less than necessary". Every citizen must be ...

Brochure | 27-08-2018

Zinnige Zorg implementation of the appropriate care of expensive drugs in cases of castration-refractory prostate cancer (CRPC)

This letter is to inform the Minister of Medical Care and Sport about the changes made by parties during the implementation phase ...

Letter | 23-08-2018

Hydrocortisone sodium phosphate (Softacor®) for the treatment of mild non-infectious allergic or inflammatory conjunctival diseases

Zorginstituut Nederland has carried out an assessment of the medicinal product hydrocortisone sodium phosphate (Softacor®) can be ...

Report | 06-08-2018

Zinnige Zorg room for improvement analysis: Peripheral Arterial Disease

This Room for Improvement Analysis describes the research and the resulting actions and agreements that focus on further ...

Report | 01-08-2018

Roflumilast (Daxas®) for maintenance treatment of severe chronic obstructive lung disease (COPD)

Zorginstituut Nederland has carried out an assessment of whether roflumilast (Daxas®) is interchangeable with a drug currently ...

Report | 31-07-2018

SGLT2 inhibitors for the treatment of type 2 diabetes: relaxing List 2 conditions

Zorginstituut Nederland has carried out a substantive assessment of whether the existing list 2 conditions for SGLT2 inhibitors ...

Report | 31-07-2018

Teduglutide (Revestive®) for the treatment of short bowel syndrome

The Minister of Health, Welfare and Sport (VWS) has asked Zorginstituut Nederland to carry out an assessment of teduglutide ...

Report | 31-07-2018

Obeticholic acid (Ocaliva®) for the treatment of primary biliary cholangitis

Zorginstituut Nederland carried out an assessment of whether obeticholic acid (Ocaliva®) is interchangeable with a drug currently ...

Report | 18-07-2018

Cariprazine (Reagila®) for the treatment of schizophrenia

The Minister of Health, Welfare and Sport (WVS) asked Zorginstituut Nederland (National Health Care Institute) to carry out a ...

Report | 04-06-2018